Saruparib
5-[4-[(7-ethyl-6-oxo-5H-1,5-naphthyridin-3-yl)methyl]piperazin-1-yl]-N-methylpyridine-2-carboxamide
Molecular Identity
Saruparib
5-[4-[(7-ethyl-6-oxo-5H-1,5-naphthyridin-3-yl)methyl]piperazin-1-yl]-N-methylpyridine-2-carboxamide
PubChem CID: 155586901
2D Structure
Properties
C22H26N6O2
Molecular Formula
406.50
Molecular Weight
g/mol
406.2117
Exact Mass
Da
1.1
XLogP
Drug-like (Lipinski: < 5)
90.5
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
6
H-Bond Acceptors
660
Complexity
SMILES
Canonical SMILES
SMILES: CCC1=CC2=C(C=C(C=N2)CN3CCN(CC3)C4=CN=C(C=C4)C(=O)NC)NC1=OIsomeric SMILES
SMILES: CCC1=CC2=C(C=C(C=N2)CN3CCN(CC3)C4=CN=C(C=C4)C(=O)NC)NC1=OSynonyms(20)
AZD53052589531-76-8SaruparibAZD-530516MZ1V3RBTAzd 5305RefChem:1160445-(4-((7-ethyl-6-oxo-5,6-dihydro-1,5-naphthyridin-3-yl)methyl)piperazin-1-yl)-N-methylpyridine-2-carboxamidesaruparib [INN]5-(4-((7-Ethyl-6-oxo-5,6-dihydro-1,5-naphthyridin-3-yl)methyl)piperazin-1-yl)-N-methylpicolinamideSCHEMBL22912701EX-A5234NSC834196NSC-834196MS-26971
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Saruparib
Loading drug network...